{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T11:58:46Z","timestamp":1790337526931,"version":"4.1.0"},"reference-count":51,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:00:00Z","timestamp":1790294400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Opioid use disorder (OUD) is associated with persistent drug use, high relapse rates, and significant morbidity, mortality, and psychosocial harm. While Long-Acting Injectable Buprenorphine (LAIB), marketed as Buvidal, offers improved pharmacological management over traditional opioid substitution therapy (OST), the mental clarity provided by LAIB often surfaces unresolved trauma and mental health needs. Integrating trauma-informed psychological care alongside pharmacological intervention is increasingly recognized as critical to optimize recovery outcomes for individuals with co-occurring psychiatric co-morbidities and substance use disorder.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This evaluation aimed to explore client experience of the Buvidal Psychological Support Service, a tiered trauma-informed psychological service, piloted to support individuals with OUD receiving LAIB in Wales, UK.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Qualitative data were derived from nine semi-structured interviews with BPSS service users, exploring their experiences, perceived impacts, and recovery journeys through reflexive thematic analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Findings indicated the transition to LAIB was often transformative but exposed trauma and emotional difficulties previously masked by substance use, making the availability of timely psychological support critical for maintaining abstinence and wellbeing. Clients valued the BPSS\u2019s rapid access, continuity, person-centered care and non-judgmental ethos, reporting enhanced agency, emotional regulation, and social reintegration. Relapse prevention was strongly linked to psychological support alongside pharmacological treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The findings suggest that participants experienced BPSS as a valuable adjunct to LAIB, particularly where increased mental clarity brought trauma-related and emotional difficulties into focus. The pilot highlights the potential value of integrating trauma-informed psychological support within LAIB pathways, while further evaluation is needed to assess transferability and longer-term outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fpsyt.2026.1924312","type":"journal-article","created":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T11:04:27Z","timestamp":1790334267000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Trauma-informed psychological support alongside long-acting injectable buprenorphine: clients\u2019 perspectives on the Buvidal psychological support service (BPSS) pilot in Wales"],"prefix":"10.3389","volume":"17","author":[{"given":"Gareth","family":"Roderique-Davies","sequence":"first","affiliation":[{"name":"Addictions Research Group, Applied Psychology Research and Innovation Group, Faculty of Life Sciences and Education, University of South Wales","place":["Pontypridd, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nyle H.","family":"Davies","sequence":"additional","affiliation":[{"name":"Addictions Research Group, Applied Psychology Research and Innovation Group, Faculty of Life Sciences and Education, University of South Wales","place":["Pontypridd, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darren","family":"Quelch","sequence":"additional","affiliation":[{"name":"Addictions Research Group, Applied Psychology Research and Innovation Group, Faculty of Life Sciences and Education, University of South Wales","place":["Pontypridd, United Kingdom"]},{"name":"Alcohol care and clinical toxicology team, Sandwell and West Birmingham NHS Trust","place":["Birmingham, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Jones","sequence":"additional","affiliation":[{"name":"Addictions Research Group, Applied Psychology Research and Innovation Group, Faculty of Life Sciences and Education, University of South Wales","place":["Pontypridd, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chioma","family":"Nwozo","sequence":"additional","affiliation":[{"name":"Addictions Research Group, Applied Psychology Research and Innovation Group, Faculty of Life Sciences and Education, University of South Wales","place":["Pontypridd, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucie","family":"James","sequence":"additional","affiliation":[{"name":"Buvidal Psychological Support Service, Newport Road, Cardiff and Vale University Health Board","place":["Cardiff, Wales, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Melichar","sequence":"additional","affiliation":[{"name":"Buvidal Psychological Support Service, Newport Road, Cardiff and Vale University Health Board","place":["Cardiff, Wales, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Tucker","sequence":"additional","affiliation":[{"name":"Buvidal Psychological Support Service, Newport Road, Cardiff and Vale University Health Board","place":["Cardiff, Wales, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lewis","family":"Jones","sequence":"additional","affiliation":[{"name":"Buvidal Psychological Support Service, Newport Road, Cardiff and Vale University Health Board","place":["Cardiff, Wales, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Dennie","sequence":"additional","affiliation":[{"name":"Buvidal Psychological Support Service, Newport Road, Cardiff and Vale University Health Board","place":["Cardiff, Wales, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Noonan","sequence":"additional","affiliation":[{"name":"Buvidal Psychological Support Service, Newport Road, Cardiff and Vale University Health Board","place":["Cardiff, Wales, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katy","family":"Holloway","sequence":"additional","affiliation":[{"name":"Substance Use Research Group, Crime, Security and Justice Research and Innovation Group, Faculty of Life Sciences and Education, University of South Wales","place":["Pontypridd, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josh","family":"Molina","sequence":"additional","affiliation":[{"name":"Addictions Research Group, Applied Psychology Research and Innovation Group, Faculty of Life Sciences and Education, University of South Wales","place":["Pontypridd, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosemary","family":"Greenwood","sequence":"additional","affiliation":[{"name":"Buvidal Psychological Support Service, Newport Road, Cardiff and Vale University Health Board","place":["Cardiff, Wales, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bev","family":"John","sequence":"additional","affiliation":[{"name":"Addictions Research Group, Applied Psychology Research and Innovation Group, Faculty of Life Sciences and Education, University of South Wales","place":["Pontypridd, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/S2215-0366(23)00095-0","article-title":"Buprenorphine versus methadone for the treatment of opioid dependence: a systematic review and meta-analysis of randomised and observational studies","volume":"10","author":"Degenhardt","year":"2023","journal-title":"Lancet Psychiatry"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1111\/acps.13088","article-title":"Reduction in mortality risk with opioid agonist therapy: a systematic review and meta-analysis","volume":"140","author":"Bahji","year":"2019","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2022.749033","article-title":"Effectiveness of interventions for prevention of common infections among opioid users: A systematic review of systematic reviews","volume":"10","author":"Puzhko","year":"2022","journal-title":"Front Public Health"},{"key":"B4","unstructured":"Expansion of Life-Saving Opioid Overdose Treatment\n          \n          2024"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2023.102311","article-title":"Superiority and cost-effectiveness of monthly extended-release buprenorphine versus daily standard of care medication: a pragmatic, parallel-group, open-label, multicentre, randomised, controlled, phase 3 trial","volume":"66","author":"Marsden","year":"2023","journal-title":"EClinicalMedicine"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011117.pub3","article-title":"Opioid agonist treatment for people who are dependent on pharmaceutical opioids","volume":"9","author":"Nielsen","year":"2022","journal-title":"Cochrane Database Systematic Rev"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2021.0976","article-title":"Association of opioid agonist treatment with all-cause mortality and specific causes of death among people with opioid dependence: A systematic review and meta-analysis","volume":"78","author":"Santo","year":"2021","journal-title":"JAMA Psychiatry"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-2667(19)30060-X","article-title":"The effect of entry and retention in opioid agonist treatment on contact with the criminal justice system among opioid-dependent people: A retrospective cohort study","volume":"4","author":"Gisev","year":"2019","journal-title":"Lancet Public Health"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1177\/1049732311432718","article-title":"Methadone as social control: Institutionalized stigma and the prospect of recovery","volume":"22","author":"Harris","year":"2012","journal-title":"Qual Health Res"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1080\/00909882.2023.2180770","article-title":"\u2018Chemical jail\u2019: Culture-centered theorizing of carcerality in methadone maintenance treatment and addiction recovery in the United States","volume":"51","author":"Stanley","year":"2023","journal-title":"J Appl Communication Res"},{"key":"B11","unstructured":"It Takes Away Your Liquid Handcuffs: A Peer-Led Review of Buvidal\n          \n          2022"},{"key":"B12","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.jsat.2019.06.007","article-title":"Opioid users' willingness to receive prolonged-release buprenorphine depot injections for opioid use disorder","volume":"104","author":"Tompkins","year":"2019","journal-title":"J Subst Abuse Treat"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1080\/09687637.2023.2165041","article-title":"Qualitative study of patients\u2019 decisions to initiate injectable depot buprenorphine for opioid use disorder: the role of information and other factors","volume":"31","author":"Neale","year":"2023","journal-title":"Drugs: Education Prev Policy"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.9041","article-title":"Patient-reported outcomes of treatment of opioid dependence with weekly and monthly subcutaneous depot vs daily sublingual buprenorphine: A randomized clinical trial","volume":"4","author":"Lintzeris","year":"2021","journal-title":"JAMA Netw Open"},{"key":"B15","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1080\/17581869.2025.2555164","article-title":"Buvidal\/Brixadi \u2013 a long-acting injectable buprenorphine formulation for the treatment of opioid dependence","volume":"15","author":"Lintzeris","year":"2025","journal-title":"Pain Manage"},{"key":"B16","volume-title":"Evaluation of Buvidal: Synthesis of Findings","author":"Holloway","year":"2026"},{"key":"B17","doi-asserted-by":"publisher","first-page":"395","DOI":"10.2174\/1570159043359477","article-title":"Buprenorphine: a unique drug with complex pharmacology","volume":"2","author":"Lutfy","year":"2004","journal-title":"Curr Neuropharmacol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/0376-8716(85)90067-5","article-title":"Buprenorphine","volume":"14","author":"Lewis","year":"1985","journal-title":"Drug Alcohol Depend"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002207.pub4","article-title":"Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence","author":"Mattick","year":"2014","journal-title":"Cochrane Database Systematic Rev"},{"key":"B20","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1111\/dar.13616","article-title":"Exploring patient experience and satisfaction with depot buprenorphine formulations: A mixed-methods study","volume":"42","author":"Allen","year":"2023","journal-title":"Drug Alcohol Rev"},{"key":"B21","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13011-022-00474-2","article-title":"Patient perspectives on depot buprenorphine treatment for opioid addiction - a qualitative interview study","volume":"17","author":"Johnson","year":"2022","journal-title":"Subst Abuse Treatment Prevention Policy"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2023.104221","article-title":"Conceptualising retention in treatment with long-acting injectable buprenorphine (for opioid use disorder) as a journey: Findings from a longitudinal qualitative study","volume":"122","author":"Parkin","year":"2023","journal-title":"Int J Drug Policy"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1080\/10826084.2024.2392553","article-title":"Long-acting injectable buprenorphine for opioid use disorder: A qualitative analysis of patients\u2019 interpersonal relationships during the first year of treatment","volume":"59","author":"Neale","year":"2024","journal-title":"Subst Use Misuse"},{"key":"B24","unstructured":"Drug Misuse and Dependence: UK Guidelines on Clinical Management (Orange Book)\n          \n          2017"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1177\/2150132720932017","article-title":"Mental health and psychosocial needs of patients being treated for opioid use disorder in a primary care residency clinic","volume":"11","author":"Hooker","year":"2020","journal-title":"J Primary Care Community Health"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2019.106149","article-title":"Childhood adversity and mental health comorbidity in men and women with opioid use disorders","volume":"102","author":"Evans","year":"2020","journal-title":"Addict Behav"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2020.108244","article-title":"The impact of psychiatric comorbidity on treatment discontinuation among individuals receiving medications for opioid use disorder","volume":"216","author":"Friesen","year":"2020","journal-title":"Drug Alcohol Depend"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2024.111253","article-title":"Interpersonal trauma, shame, and substance use: A systematic review","volume":"258","author":"Bhuptani","year":"2024","journal-title":"Drug Alcohol Depend"},{"key":"B29","doi-asserted-by":"crossref","DOI":"10.4324\/9781003032762-42","article-title":"Beyond the medical model","volume-title":"Evaluating the Brain Disease Model of Addiction","author":"Mat\u00e9","year":"2022"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.142.11.1259","article-title":"The self-medication hypothesis of addictive disorders: focus on heroin and cocaine dependence","volume":"142","author":"Khantzian","year":"1985","journal-title":"Am J Psychiatry"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2022.107431","article-title":"A trauma model of substance use: Elaboration and preliminary validation","volume":"134","author":"Schimmenti","year":"2022","journal-title":"Addict Behav"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2020.108459","article-title":"Prevalence of childhood maltreatment among people with opioid use disorder: A systematic review and meta-analysis","volume":"219","author":"Santo","year":"2021","journal-title":"Drug Alcohol Depend"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-2667(17)30118-4","article-title":"The effect of multiple adverse childhood experiences on health: a systematic review and meta-analysis","volume":"2","author":"Hughes","year":"2017","journal-title":"Lancet Public Health"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1111\/adb.13047","article-title":"A randomised, double-blind study investigating the relationship between early childhood trauma and the rewarding effects of morphine","volume":"26","author":"Carlyle","year":"2021","journal-title":"Addict Biol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004147.pub4","article-title":"Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone for treatment of opioid dependence","author":"Amato","year":"2011","journal-title":"Cochrane Database Systematic Rev"},{"key":"B36","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1097\/ADM.0000000000000193","article-title":"A systematic review on the use of psychosocial interventions in conjunction with medications of the treatment of opioid addiction","volume":"10","author":"Dugosh","year":"2016","journal-title":"J Addict Med"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2020.108434","article-title":"Forty-eight years of research on psychosocial interventions in the treatment of opioid use disorder: A scoping review","volume":"218","author":"Wild","year":"2021","journal-title":"Drug Alcohol Depend"},{"key":"B38","volume-title":"Trauma and Recovery","author":"Herman","year":"1992"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1093\/intqhc\/mzm042","article-title":"Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups","volume":"19","author":"Tong","year":"2007","journal-title":"Int J For Qual Health Care"},{"key":"B40","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1037\/qup0000196","article-title":"Conceptual and design thinking for thematic analysis","volume":"9","author":"Braun","year":"2022","journal-title":"Qual Psychol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1007\/s11135-021-01182-y","article-title":"A worked example of Braun and Clarke\u2019s approach to reflexive thematic analysis","volume":"56","author":"Byrne","year":"2022","journal-title":"Qual Quant"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1007\/s11135-017-0574-8","article-title":"Saturation in qualitative research: exploring its conceptualization and operationalization","volume":"52","author":"Saunders","year":"2018","journal-title":"Qual Quant"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2011.12.013","article-title":"The role of therapeutic alliance in substance use disorder treatment for young adults","volume":"43","author":"Urbanoski","year":"2012","journal-title":"J Subst Abuse Treat"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2004.00935.x","article-title":"The role of the therapeutic alliance in the treatment of substance misuse: a critical review of the literature","volume":"100","author":"Meier","year":"2005","journal-title":"Addiction"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1080\/09687637.2025.2506415","article-title":"Patient satisfaction with long-acting injectable buprenorphine: What needs to be measured from the patient\u2019s perspective","volume":"33","author":"Neale","year":"2026","journal-title":"Drugs: Education Prev Policy"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.dadr.2025.100328","article-title":"Long acting injectable buprenorphine: Perspectives from service-users, staff and stakeholders","volume":"15","author":"Fish","year":"2025","journal-title":"Drug Alcohol Depend Rep"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1111\/add.16171","article-title":"How do patients feel during the first 72\u2009h after initiating long-acting injectable buprenorphine? An embodied qualitative analysis","volume":"118","author":"Neale","year":"2023","journal-title":"Addiction"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.dadr.2026.100421","article-title":"More than a medication: The lived meaning and value of long-acting injectable buprenorphine","volume":"19","author":"Donaldson","year":"2026","journal-title":"Drug Alcohol Depend Rep"},{"key":"B49","doi-asserted-by":"publisher","first-page":"105","DOI":"10.2147\/SAR.S440214","article-title":"Risk of relapse following discharge from non-hospital residential opioid use disorder treatment: A systematic review of studies published from 2018 to 2022","volume":"16","author":"Ware","year":"2025","journal-title":"Subst Abuse Rehabil"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2024.1295818","article-title":"Stigma toward substance use disorders: a multinational perspective and call for action","volume":"15","author":"El Hayek","year":"2024","journal-title":"Front Psychiatry"},{"key":"B51","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1177\/15291006231198193","article-title":"Stigma toward substance dependence: Causes, consequences, and potential interventions","volume":"24","author":"Krendl","year":"2023","journal-title":"psychol Sci Public Interest"}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2026.1924312\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T11:04:29Z","timestamp":1790334269000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2026.1924312\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,25]]},"references-count":51,"alternative-id":["10.3389\/fpsyt.2026.1924312"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2026.1924312","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,25]]},"article-number":"1924312"}}